Yes, targeting mRNA is a promising strategy for cancer treatment. Antisense oligonucleotides (ASOs) and small interfering RNA (siRNA) are designed to bind to specific mRNA molecules, thereby preventing their translation into proteins. This approach can effectively reduce the expression of oncogenes or other proteins that drive cancer progression. Furthermore, mRNA vaccines are being explored to stimulate the immune system to recognize and attack cancer cells.